News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,949 Results
Type
Article (86795)
Company Profile (704)
Press Release (764449)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (232791)
Career Advice (4132)
Deals (39754)
Drug Delivery (129)
Drug Development (91078)
Employer Resources (198)
FDA (18172)
Job Trends (17359)
News (396765)
Policy (39808)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (106)
Alliances (56973)
ALS (115)
Alzheimer's disease (1548)
Antibody-drug conjugate (ADC) (186)
Approvals (18118)
Artificial intelligence (385)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (127)
Biotechnology (481)
Bladder cancer (96)
Brain cancer (39)
Breast cancer (381)
Cancer (2994)
Cardiovascular disease (240)
Career advice (3540)
Career pathing (34)
CAR-T (202)
CDC (40)
Cell therapy (559)
Cervical cancer (24)
Clinical research (74163)
Collaboration (1077)
Company closure (3)
Compensation (663)
Complete response letters (30)
COVID-19 (2898)
CRISPR (65)
C-suite (326)
Cystic fibrosis (117)
Data (2948)
Decentralized trials (2)
Denatured (49)
Depression (68)
Diabetes (374)
Diagnostics (6970)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (172)
Drug pricing (150)
Drug shortages (35)
Duchenne muscular dystrophy (130)
Earnings (97441)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131371)
Executive appointments (902)
FDA (19829)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (986)
Gene editing (144)
Generative AI (38)
Gene therapy (426)
GLP-1 (924)
Government (5248)
Grass and pollen (6)
Guidances (180)
Healthcare (20915)
Huntington's disease (32)
IgA nephropathy (42)
Immunology and inflammation (175)
Immuno-oncology (9)
Indications (40)
Infectious disease (3083)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17903)
IRA (55)
Job creations (5192)
Job search strategy (2863)
Kidney cancer (15)
Labor market (55)
Layoffs (584)
Leadership (26)
Legal (10132)
Liver cancer (84)
Lung cancer (423)
Lymphoma (207)
Machine learning (9)
Management (65)
Manufacturing (420)
MASH (94)
Medical device (14706)
Medtech (14711)
Mergers & acquisitions (22550)
Metabolic disorders (944)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (138)
Neuropsychiatric disorders (40)
Neuroscience (2275)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (486)
Opinion (288)
Ovarian cancer (101)
Pain (116)
Pancreatic cancer (121)
Parkinson's disease (197)
Partnered (25)
Patents (307)
Patient recruitment (155)
Peanut (55)
People (65653)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22896)
Phase II (32201)
Phase III (24245)
Pipeline (1630)
Policy (234)
Postmarket research (3552)
Preclinical (10337)
Press Release (72)
Prostate cancer (145)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (506)
Real estate (7400)
Recruiting (76)
Regulatory (27073)
Reports (61)
Research institute (2664)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (57)
Schizophrenia (92)
Series A (165)
Series B (109)
Service/supplier (30)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (64)
The Weekly (90)
Vaccines (895)
Venture capital (54)
Weight loss (328)
Women's health (48)
Worklife (20)
Date
Today (6)
Last 7 days (642)
Last 30 days (2346)
Last 365 days (33955)
2025 (17488)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50483)
Australia (8873)
California (7619)
Canada (2346)
China (711)
Colorado (331)
Connecticut (342)
Delaware (200)
Europe (115805)
Florida (1128)
Georgia (260)
Hawaii (2)
Idaho (66)
Illinois (729)
India (32)
Indiana (382)
Iowa (18)
Japan (227)
Kansas (115)
Kentucky (32)
Louisiana (18)
Maine (73)
Maryland (1088)
Massachusetts (5827)
Michigan (274)
Minnesota (477)
Mississippi (3)
Missouri (98)
Montana (32)
Nebraska (26)
Nevada (81)
New Hampshire (73)
New Jersey (2135)
New Mexico (31)
New York (2146)
North Carolina (1226)
North Dakota (10)
Northern California (3277)
Ohio (245)
Oklahoma (17)
Oregon (48)
Pennsylvania (1632)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2797)
Tennessee (127)
Texas (1159)
United States (28829)
Utah (227)
Virginia (208)
Washington D.C. (80)
Washington State (676)
West Virginia (4)
Wisconsin (83)
There are 851,949 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pliant Therapeutics Provides Update on BEACON-IPF
June 30, 2025
·
6 min read
Press Releases
Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR
June 30, 2025
·
6 min read
Press Releases
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
June 30, 2025
·
1 min read
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside experts.
June 30, 2025
·
6 min read
·
Natalia Mesa
Rare diseases
Ultrarare Therapies Could Be Reality with Advances in Tech, Delivery and Regulation
Changing how biopharmas package their products, how regulators review new drugs and how mutated genes are fixed could make ultrarare disease treatments possible.
June 30, 2025
·
6 min read
·
Dan Samorodnitsky
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an approval in bladder cancer, and more key regulatory nods from the past month.
June 30, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Exicure, Inc. Reports First Quarter 2025 Financial Results
June 27, 2025
·
6 min read
Press Releases
Theralase(R) Extends Warrants
June 27, 2025
·
3 min read
Press Releases
US Patent Issued for the First Nutraceutical Supplement Clinically Proven to Preserve or Improve Hearing, with Additional Claims to Reduce Dementia Risk
ACEMg® is designed to preserve hearing in people who have experienced hearing loss
June 27, 2025
·
1 min read
Press Releases
Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer
June 27, 2025
·
5 min read
1 of 85,195
Next
